Liposomal BPC-157 Quicksilver Scientific Liposomal BPC-157 is an oral, multi-purpose, high absorption peptide formula, deriving from the BPC protein naturally found in the human digestive tract
If taking the oral capsules, the standard dosage is one 500mcg capsule per day, in the injectable form the standard dosage is 200mcg taken on an empty stomach daily
AY has given paid lectures and sat on advisory boards for the following companies with drugs used in affective and related disorders: Flow Neuroscience, Novartis, Roche, Janssen, Takeda, Noema pharma, Compass, Astrazenaca, Boehringer Ingelheim, Eli Lilly, LivaNova, Lundbeck, Sunovion, Servier, Livanova, Janssen, Allegan, Bionomics, Sumitomo Dainippon Pharma, Sage, Neurocentrx
Generally, the discomfort experienced during fillers and injectables varies depending on individual pain tolerance, the area being treated, and the specific product used
These are not optional nutrients, they are in fact central to mitochondrial energy production
The following protocol is adapted from ref 10